Stockreport

Alumis and ACELYRIN File Joint Definitive Proxy Statement for Proposed Merger

Alumis Inc.  (ALMS) 
PDF Stockholders to benefit from differentiated late-stage portfolio of therapies and strong balance sheet Boards unanimously recommend stockholders vote “FOR” the merger [Read more]